124791-75-9Relevant academic research and scientific papers
COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY
-
Page/Page column, (2014/06/24)
Compounds of formula (I) described herein act both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists and are useful for the prevention and/or treatment of broncho-obstructive or inflammatory diseases.
COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY
-
, (2014/06/24)
The present invention relates to compounds acting both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists, to processes for their preparation, to compositions comprising them, to therapeutic uses and combinations with other pharmaceutical active ingredients.
ELECTROOXIDATIVE REARRANGEMENT OF CONJUGATED ARYLOLEFINS TO ARYLACETALDEHYDE DIMETHYL ACETALS
Shono, Tatsuya,Matsumura, Yoshihiro,Katoh, Susumu,Ikeda, Kaoru,Fujita, Tetsuhiro,Kamada, Tohru
, p. 5309 - 5312 (2007/10/02)
Electrochemical oxidation of conjugated arylolefins 1 in trimethyl orthoformate containing iodine gave arylacetaldehyde dimethyl acetals 2 in high yields.
